The analysis identified three genes as prognostic factors in patients with GC, and that patients with low expression of CXCR4, DLC1, and MAP1LC3C, (p = 0.001, p = 0.046, and p = 0.021) had better prognoses than those with high expression (Figure 2A–2C). This evidence concerns the gene DLC1 and gastric cancer.